| Attribute | Value | References |
|---|---|---|
| Symbol | RPL13A | |
| Name | Ribosomal Protein L13A | |
| Chromosome | 19q13.3 | [1] |
| NCBI Gene ID | 6145 | [1:1] |
| UniProt ID | P32969 | [2] |
| Ensembl ID | ENSG00000067533 | [3] |
RPL13A (Ribosomal Protein L13A) encodes a component of the large (60S) ribosomal subunit. Ribosomal proteins like RPL13A are essential for protein synthesis and have been increasingly recognized for their roles in regulating gene expression beyond canonical translation, including involvement in neurodevelopment and neurodegeneration.
RPL13A is a member of the ribosomal protein L13P family and constitutes an integral component of the 60S large ribosomal subunit. The ribosome is the cellular machinery responsible for protein synthesis (translation), reading mRNA sequences and assembling amino acids into polypeptide chains. The 60S subunit performs the peptidyl transferase activity, catalyzing the formation of peptide bonds between amino acids during translation elongation.
As part of the large ribosomal subunit, RPL13A contributes to the structural integrity of the ribosome and participates in binding of translation factors. Ribosomal proteins are highly conserved across species, reflecting their fundamental importance in cellular physiology.
Beyond its structural role in the ribosome, RPL13A has a distinct function in the GAIT complex (IFN-γ-activated inhibitor of translation), a heterotetrameric protein complex that mediates interferon-γ (IFN-γ)-dependent translational repression of specific mRNAs.
The GAIT complex consists of four proteins:
RPL13A serves as the ribosomal docking site for the GAIT complex, tethering the complex to the ribosome. When activated by IFN-γ signaling, the GAIT complex binds to specific 3' UTR elements in target mRNAs, represses their translation, and plays a critical role in resolving inflammation by controlling the expression of inflammatory mediators.
RPL13A is ubiquitously expressed in all tissues, with high expression in tissues with active protein synthesis, including:
In the brain, RPL13A is expressed in both neurons and glial cells, consistent with its fundamental role in cellular protein synthesis. The protein is localized primarily in the cytoplasm, associated with ribosomes in the rough endoplasmic reticulum (RER) in protein-secreting cells.
The ribosomal apparatus has emerged as a critical player in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). Multiple mechanisms link ribosomal dysfunction to neurodegeneration:
In Alzheimer's disease, global protein synthesis is often dysregulated. Key observations include:
RPL13A, as part of the translational machinery, is affected by these broader patterns of dysregulation. The GAIT complex function is particularly relevant given the inflammatory component of AD pathophysiology.
Parkinson's disease pathology involves:
Ribosomal biogenesis stress—where the cell's capacity to produce functional ribosomes is compromised—has been implicated in PD. Mutations in genes involved in rib biogenesis (e.g., GBA, ATP13A2, RPL5) are associated with PD risk. While RPL13A itself is not a PD risk gene, ribosomal stress contributes to the broader pathogenic cascade.
Altered RPL13A expression has been reported in various cancers:
However, the relationship between RPL13A and cancer is less direct than its role in neurodegeneration.
Ribosome biogenesis is one of the most energy-intensive cellular processes, requiring:
RPL13A is synthesized in the cytoplasm and incorporated into pre-60S subunits during assembly. The process is regulated by:
The GAIT complex represents a specialized regulatory mechanism:
In the brain, chronic neuroinflammation is a hallmark of AD and PD. The GAIT pathway may contribute to dysregulated inflammatory responses in neurodegeneration.
Therapeutic strategies targeting ribosomal function in neurodegeneration include:
These compounds have research but not therapeutic applications due to toxicity.
RPL13A in the GAIT complex: The ribosomal protein serves as an anchor for the IFN-γ-activated translational repressor complex, linking inflammatory signaling to translational control.
Ribosomal stress in neurodegeneration: Studies show that ribosomal biogenesis is impaired in AD and PD brains, with downstream effects on protein homeostasis.
Ribosomal protein mutations: While RPL13A mutations are not classically associated with neurodegeneration, mutations in other ribosomal proteins (RPL5, RPS14) cause Diamond-Blackfan anemia and predispose to cancer.
DRiPs and protein aggregation: Defective ribosomal products may contribute to proteotoxic stress in neurodegeneration.